Fusion Pharmaceuticals In... (FUSN)
NASDAQ: FUSN
· Real-Time Price · USD
21.55
0.03 (0.14%)
At close: Jun 03, 2024, 10:00 PM
Fusion Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 28.26M | 61.92M | 26.79M | 32.02M | 53.62M | 43.86M | 106.05M | 61.52M | 59.21M | 52.9M | 38.38M | 27.61M | 41.07M |
Short-Term Investments | 182.74M | 172.15M | 164.56M | 166.07M | 156.23M | 127.01M | 99.43M | 136.9M | 137.6M | 147.9M | 154.24M | 150.9M | 186.15M |
Long-Term Investments | 73.43M | 14.58M | 15.93M | 28.42M | 11.34M | 15.76M | 1.02M | 1.02M | 9.9M | 19.99M | 45.55M | 81.97M | 51M |
Other Long-Term Assets | 652K | 849K | 2.32M | 2.67M | 6.31M | 9.18M | 8.67M | 9.06M | 9.36M | 9.42M | 9.01M | 4.08M | 1.74M |
Receivables | 4.68M | 4.21M | 2.37M | 2.4M | 2.54M | 1.72M | 2.92M | 2.6M | 1.69M | 357K | 2.29M | 1.35M | 979K |
Inventory | n/a | n/a | 8.23M | 5.67M | -4.4M | -9.87M | 6.81M | 5.51M | 5.85M | 10.38M | 7.8M | 5.06M | 5.18M |
Other Current Assets | 5.24M | 5.1M | 1.32M | 1.7M | 1.3M | 509K | 635K | 540K | 422K | 233K | 311K | 227K | 478K |
Total Current Assets | 220.92M | 243.4M | 203.26M | 207.86M | 220.62M | 179M | 215.85M | 207.07M | 204.78M | 211.76M | 203.01M | 185.16M | 233.85M |
Property-Plant & Equipment | 24.45M | 23.9M | 24.98M | 23.34M | 22.98M | 10.31M | 9.82M | 9.77M | 9.94M | 9.45M | 9.41M | 9.88M | 10.06M |
Goodwill & Intangibles | n/a | -849K | n/a | n/a | n/a | n/a | -1.02M | -1.02M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 102.9M | 42.44M | 50.11M | 60.43M | 45.93M | 40.07M | 22.65M | 21.06M | 31.18M | 40.51M | 65.29M | 97M | 63.45M |
Total Assets | 323.81M | 285.84M | 253.38M | 268.29M | 266.55M | 219.06M | 238.49M | 228.13M | 235.96M | 252.27M | 268.3M | 282.16M | 297.31M |
Account Payables | 2.5M | 1.86M | 1.06M | 2.06M | 1.9M | 2.69M | 1.31M | 1.55M | 1.77M | 2.19M | 3.8M | 685K | 1.02M |
Deferred Revenue | 333K | 333K | 727K | 769K | 768K | 924K | 412K | 707K | 1.1M | 1.54M | 2.29M | 1.73M | 1M |
Short-Term Debt | 4.29M | 4.16M | 6.17M | 5.36M | 4.64M | 1.44M | 1.43M | 1.44M | 1.43M | 1.22M | 1.33M | 1.26M | 1.19M |
Other Current Liabilities | 13.63M | 9.86M | 9.53M | 8.91M | 10.02M | 10.01M | 10.26M | 7.88M | 7.87M | 7.56M | 6.15M | 5.68M | 4.41M |
Total Current Liabilities | 20.76M | 16.22M | 17.48M | 17.09M | 17.32M | 15.07M | 13.41M | 11.58M | 12.18M | 12.51M | 13.56M | 9.37M | 7.62M |
Long-Term Debt | 49.69M | 34.77M | 46.46M | 45.27M | 45.43M | 38.81M | 38.98M | 14.86M | 5.55M | 5.51M | 5.78M | 6.08M | 6.32M |
Other Long-Term Liabilities | 301K | 301K | 299K | 299K | 299K | 299K | 297K | 297K | 297K | 297K | 295K | 295K | 295K |
Total Long-Term Liabilities | 61.23M | 47.14M | 47.43M | 48.23M | 48.39M | 41.78M | 41.94M | 17.65M | 8.35M | 8.3M | 8.24M | 9.24M | 10.62M |
Total Liabilities | 81.98M | 63.36M | 64.91M | 65.33M | 65.72M | 56.84M | 55.35M | 29.23M | 20.53M | 20.82M | 21.81M | 18.61M | 18.24M |
Total Debt | 64.55M | 50.33M | 52.63M | 50.62M | 50.06M | 40.25M | 40.41M | 16.29M | 6.99M | 6.72M | 7.11M | 7.34M | 7.52M |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -410.43M | -376.76M | -348.58M | -331.33M | -306.15M | -281.86M | -257.25M | -233.23M | -214.16M | -194.25M | -177.01M | -157.59M | -130.73M |
Comprehensive Income | -582K | 237K | -841K | -252K | -85K | -469K | -1.26M | -1.06M | -578K | -115K | 63K | 337K | 283K |
Shareholders Equity | 241.83M | 222.48M | 188.47M | 202.96M | 200.83M | 162.22M | 183.14M | 198.91M | 215.43M | 231.46M | 246.5M | 263.55M | 279.07M |
Total Investments | 256.17M | 186.74M | 180.49M | 194.5M | 167.56M | 142.77M | 99.43M | 136.9M | 147.5M | 167.88M | 199.79M | 232.88M | 237.15M |